Play the video
Premium Pharma-grade Hyaluronic Acid (Sodium Hyaluronate)
Premium Pharma-grade Polynucleotides
Cosmetic grade DNA
Discover HTL Biotechnology’s new recombinant human collagen with unique properties.
Building on the success of Hyaluronic Acid, HTL Biotechnology now wishes to bring new opportunities with Heparosan.
Ultra-low molecular weight Hyaluronan
From 17 February, we celebrate the Lunar New Year and step into the Year of the Fire Horse — a powerful symbol of drive, resilience, and forward momentum across Asia.
A time of renewal, ambition, and fresh opportunities for growth.
HTL Biotechnology took part in IMCAS 2026, one of the leading international congresses dedicated to aesthetic medicine and dermatology. This major event was an opportunity to highlight the company’s strategy, innovations, and commitment to advancing regenerative medicine through high-performance biopolymers.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
Feel the difference with HTL inside
Feel the difference with HTL inside
A global company with a heart in Brittany
HTL Biotechnology is the pioneer in the development and sustainable production of pharmaceutical grade biopolymers, used to develop life-changing treatments for millions of patients worldwide.
Backed by 30 years of expertise, we now work with more than 100 clients in 30 countries. In total, over 500 million syringes of hyaluronic acid have been safely used since 2006.
30 Years of expertise
100+ clients
30 countries of export
500+ million syringes safely used since 2006
As the market leader in pharmaceutical grade biopolymers for medical use, we work every day to :
